US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atea Pharmaceuticals, Inc.

2.87

+0.02000.70%

Post-market: 2.870.00000.00%16:05 EDT

Volume:580.39K

Turnover:1.64M

Market Cap:245.46M

PE:-1.44

High:2.88

Open:2.88

Low:2.78

Close:2.85

Loading ...

Overview Company News Filings

Atea Pharmaceuticals to Present New Data Showcasing Potential Best-in-Class Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2025

Atea Pharmaceuticals Board Approves $25 Million Share Repurchase Program

MT Newswires Live

Atea Pharmaceuticals board authorizes $25M share repurchase program

Atea Pharmaceuticals says strategic alternatives process ‘ongoing’

BRIEF-Atea Pharmaceuticals Appoints Howard H. Berman To Board Of Directors And Announces Share Repurchase Program

Atea Pharmaceuticals Inc: Authorized Repurchase of up to $25 Mln of Company's Common Stock

THOMSON REUTERS

Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program

THOMSON REUTERS

Press Release: Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program

Atea Pharmaceuticals price target lowered to $6 from $6.20 at Morgan Stanley

Atea Pharmaceuticals Doses First Patient in Late-Stage Study of Hepatitis C Virus Combination Regimen

MT Newswires Live

Atea Pharmaceuticals doses first patient in C-BEYOND, Phase 3 study

BRIEF-Atea Pharmaceuticals Announces Dosing Of First Patient In C-Beyond, Phase 3 Study Evaluating Regimen Of Bemnifosbuvir And Ruzasvir For Treatment Of Hepatitis C Virus

Atea Pharmaceuticals Announces Dosing of First Patient in C-Beyond, Phase 3 Study Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

THOMSON REUTERS

Atea Pharmaceuticals Announces Dosing of First Patient in C-BEYOND, Phase 3 Study Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Atea Pharma Reviewing Strategic Opportunities After Cutting 25% of Jobs

Atea Pharmaceuticals Highlights Actions Underway to Enhance Shareholder Value

Sector Update: Health Care Stocks Retreat Wednesday Afternoon

MT Newswires Live

Atea Shareholder Seeks Board Change, Plans to Nominate Directors at 2025 Annual Meeting

MT Newswires Live

BRIEF-The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors

the Radoff-Jec Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AVIR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVIR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVIR\",,,,,undefined,":{"symbol":"AVIR","market":"US","secType":"STK","nameCN":"Atea Pharmaceuticals, Inc.","latestPrice":2.87,"timestamp":1745524800000,"preClose":2.85,"halted":0,"volume":580389,"hourTrading":{"tag":"盘后","latestPrice":2.87,"preClose":2.87,"latestTime":"16:05 EDT","volume":8269,"amount":23732.030000000002,"timestamp":1745525109816},"delay":0,"floatShares":66356403,"shares":85525179,"eps":-1.998285,"marketStatus":"Post-Mkt","change":0.02,"latestTime":"04-24 19:56:55 EDT","open":2.88,"high":2.88,"low":2.78,"amount":1640510.218289,"amplitude":0.035088,"askPrice":3.21,"askSize":100,"bidPrice":2.78,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-1.998285,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745539200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1604030400000,"exchange":"NASDAQ","adjPreClose":2.85,"preHourTrading":{"tag":"盘前","latestPrice":2.9582,"preClose":2.85,"latestTime":"09:18 EDT","volume":1,"amount":2.9582,"timestamp":1745500696274},"postHourTrading":{"tag":"盘后","latestPrice":2.87,"preClose":2.87,"latestTime":"16:05 EDT","volume":8269,"amount":23732.030000000002,"timestamp":1745525109816},"volumeRatio":0.862883,"impliedVol":1.6809,"impliedVolPercentile":0.66},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVIR\",,,,,undefined,":{"symbol":"AVIR","floatShares":66356403,"roa":"-15.60%","roe":"-33.88%","lyrEps":-1.998285,"volumeRatio":0.862883,"shares":85525179,"dividePrice":0,"high":2.88,"amplitude":0.035088,"preClose":2.85,"low":2.78,"week52Low":2.6,"pbRate":"0.56","psRate":"1.28","week52High":4.145,"institutionHeld":0.4276,"latestPrice":2.87,"committee":0.818182,"eps":-1.998285,"divideRate":0,"volume":580389,"delay":0,"ttmEps":-1.998285,"open":2.88,"prevYearClose":3.35,"prevWeekClose":2.97,"prevMonthClose":2.99,"prevQuarterClose":2.99,"fiveDayClose":3,"twentyDayClose":3.18,"sixtyDayClose":3.1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVIR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529506765","title":"Atea Pharmaceuticals to Present New Data Showcasing Potential Best-in-Class Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2529506765","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529506765?lang=en_us&edition=fundamental","pubTime":"2025-04-23 19:00","pubTimestamp":1745406000,"startTime":"0","endTime":"0","summary":"BOSTON, April 23, 2025  -- Atea Pharmaceuticals, Inc.  , a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that the full results from the Phase 2 clinical study of Atea’s regimen of bemnifosbuvir, a nucleotide analog polymerase inhibitor, and ruzasvir, an NS5A inhibitor, for the treatment of hepatitis C virus  infection will be presented at the European Association for the Study of the Liver  Congress 2025. In addition, pharmacokinetic and safety results supporting the regimen’s profile will also be presented. The EASL Congress 2025 will take place May 7-10 in Amsterdam, Netherlands.Poster ID: TOP-251 Title: Efficacy and Safety of Bemnifosbuvir and Ruzasvir after 8 Weeks of Treatment in Patie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/atea-pharmaceuticals-present-data-showcasing-110000583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AVIR","BK4181","BK4218","KOL","SOF","BK4007","BK4085","DDI","PK"],"gpt_icon":0},{"id":"2528716100","title":"Atea Pharmaceuticals Board Approves $25 Million Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2528716100","media":"MT Newswires Live","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528716100?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:00","pubTimestamp":1744891235,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Board Approves $25 Million Share Repurchase Program","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2528974718","title":"Atea Pharmaceuticals board authorizes $25M share repurchase program","url":"https://stock-news.laohu8.com/highlight/detail?id=2528974718","media":"TIPRANKS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528974718?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:14","pubTimestamp":1744888482,"startTime":"0","endTime":"0","summary":"Atea announced that its Board has authorized, and will promptly begin executing upon, the repurchase of up to $25M of the Company’s common stock. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-board-authorizes-25m-share-repurchase-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-board-authorizes-25m-share-repurchase-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2528718977","title":"Atea Pharmaceuticals says strategic alternatives process ‘ongoing’","url":"https://stock-news.laohu8.com/highlight/detail?id=2528718977","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528718977?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:14","pubTimestamp":1744888442,"startTime":"0","endTime":"0","summary":"The company said, “As previously announced on December 16, 2024, Atea engaged Evercore, a global independent investment bank, to identify potential...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-says-strategic-alternatives-process-ongoing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-says-strategic-alternatives-process-ongoing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2528179095","title":"BRIEF-Atea Pharmaceuticals Appoints Howard H. Berman To Board Of Directors And Announces Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2528179095","media":"Reuters","labels":["executive","shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528179095?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:05","pubTimestamp":1744887914,"startTime":"0","endTime":"0","summary":"BRIEF-Atea Pharmaceuticals Appoints Howard H. Berman To Board Of Directors And Announces Share Repurchase ProgramApril 17 (Reuters) - Atea Pharmaceuticals Inc AVIR.O:ATEA PHARMACEUTICALS APPOINTS HOWA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA47GFRM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4007","BK4139","AVIR"],"gpt_icon":0},{"id":"2528797011","title":"Atea Pharmaceuticals Inc: Authorized Repurchase of up to $25 Mln of Company's Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2528797011","media":"THOMSON REUTERS","labels":["buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528797011?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:00","pubTimestamp":1744887601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA47GFRM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYA","AVIR","BK4007","BK4139"],"gpt_icon":0},{"id":"2528179709","title":"Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2528179709","media":"THOMSON REUTERS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528179709?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:00","pubTimestamp":1744887601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA47GFRM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","COYA","BK4139","AVIR"],"gpt_icon":0},{"id":"2528797700","title":"Press Release: Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2528797700","media":"Dow Jones","labels":["executive","shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528797700?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:00","pubTimestamp":1744887600,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program. Enters into Agreement with Bradley L. Radoff and Michael Torok. \"We are pleased to welcome Howard Berman to the Atea Board,\" said Jean-Pierre Sommadossi, Ph.D., Chief Executive Officer and Founder of Atea. \"We look forward to benefitting from Dr. Berman's industry experience and insights as we advance our global Phase 3 program evaluating the regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus  and our efforts to deliver value to Atea's shareholders.\". \"Atea's de-risked Phase 3 program with its potential best-in-class profile for the treatment of HCV has the potential to disrupt a multi-billion global market,\" said Dr. Berman. \"I look forward to joining the Board and working with my fellow directors on behalf of all Atea's shareholders.\". Atea also today announced that its Board has authorized, and will promptly begin executing upon, the repurchase of up","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","COYA","BK4139","BK4211","BK4007","HBMD"],"gpt_icon":0},{"id":"2526664246","title":"Atea Pharmaceuticals price target lowered to $6 from $6.20 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2526664246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526664246?lang=en_us&edition=fundamental","pubTime":"2025-04-11 21:10","pubTimestamp":1744377023,"startTime":"0","endTime":"0","summary":"Morgan Stanley lowered the firm’s price target on Atea Pharmaceuticals (AVIR) to $6 from $6.20 and keeps an Equal Weight rating on the shares. Foll...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-price-target-lowered-to-6-from-6-20-at-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-price-target-lowered-to-6-from-6-20-at-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVIR"],"gpt_icon":0},{"id":"2526213365","title":"Atea Pharmaceuticals Doses First Patient in Late-Stage Study of Hepatitis C Virus Combination Regimen","url":"https://stock-news.laohu8.com/highlight/detail?id=2526213365","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526213365?lang=en_us&edition=fundamental","pubTime":"2025-04-09 20:30","pubTimestamp":1744201851,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals  said Wednesday that the first patient has been dosed in its late-stage trial comparing the combination regimen of bemnifosbuvir and ruzasvir with the combination regimen of sofosbuvir and velpatasvir for the treatment of chronic hepatitis C virus.The bemnifosbuvir and ruzasvir regimen will be administered orally once a day for eight weeks in patients without cirrhosis or 12 weeks in patients with compensated cirrhosis, while the sofosbuvir and velpatasvir regimen will be administered orally once a day for 12 weeks, the company said.The company said infection with chronic hepatitis C virus is the leading cause of liver cancer in the US, Europe and Japan.Shares of Atea Pharmaceuticals were down more than 30% in recent premarket activity Wednesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVIR","BK4007","SSI"],"gpt_icon":0},{"id":"2526357391","title":"Atea Pharmaceuticals doses first patient in C-BEYOND, Phase 3 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2526357391","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526357391?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:11","pubTimestamp":1744197105,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals (AVIR) announced that the first patient has been dosed in C-BEYOND, Atea’s Phase 3 trial evaluating the regimen of bemnifosbuv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-doses-first-patient-in-c-beyond-phase-3-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-doses-first-patient-in-c-beyond-phase-3-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","BK4178","AVIR","BYON","BK4588"],"gpt_icon":0},{"id":"2526385352","title":"BRIEF-Atea Pharmaceuticals Announces Dosing Of First Patient In C-Beyond, Phase 3 Study Evaluating Regimen Of Bemnifosbuvir And Ruzasvir For Treatment Of Hepatitis C Virus","url":"https://stock-news.laohu8.com/highlight/detail?id=2526385352","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526385352?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:03","pubTimestamp":1744196607,"startTime":"0","endTime":"0","summary":"BRIEF-Atea Pharmaceuticals Announces Dosing Of First Patient In C-Beyond, Phase 3 Study Evaluating Regimen Of Bemnifosbuvir And Ruzasvir For Treatment Of Hepatitis C VirusApril 9 (Reuters) - Atea Phar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nTUA1ZVXW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2526635445","title":"Atea Pharmaceuticals Announces Dosing of First Patient in C-Beyond, Phase 3 Study Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus","url":"https://stock-news.laohu8.com/highlight/detail?id=2526635445","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526635445?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:00","pubTimestamp":1744196401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250409:nTUA1ZVXW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2526352622","title":"Atea Pharmaceuticals Announces Dosing of First Patient in C-BEYOND, Phase 3 Study Evaluating Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus","url":"https://stock-news.laohu8.com/highlight/detail?id=2526352622","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526352622?lang=en_us&edition=fundamental","pubTime":"2025-04-09 19:00","pubTimestamp":1744196400,"startTime":"0","endTime":"0","summary":"Regimen has Potential Best-in-Class Profile with Short Treatment Duration, Low Risk for Drug-Drug Interactions and Convenience with No Food Effect HCV Infection Remains a Significant Global Health Bur","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/09/3058258/0/en/Atea-Pharmaceuticals-Announces-Dosing-of-First-Patient-in-C-BEYOND-Phase-3-Study-Evaluating-Regimen-of-Bemnifosbuvir-and-Ruzasvir-for-Treatment-of-Hepatitis-C-Virus.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4178","BK4218","SOF","BK4181","AVIR","BK4585","BK4588","PK","BK4007"],"gpt_icon":0},{"id":"2522442339","title":"Atea Pharma Reviewing Strategic Opportunities After Cutting 25% of Jobs","url":"https://stock-news.laohu8.com/highlight/detail?id=2522442339","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522442339?lang=en_us&edition=fundamental","pubTime":"2025-03-27 02:18","pubTimestamp":1743013080,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals is reviewing strategic opportunities after cutting a quarter of its workforce.The Boston biopharmaceutical company, which develops oral antiviral treatments, said Wednesday it has engaged an independent global investment bank to identify possible opportunities, including partnerships on its Phase 3 program for a treatment of patients with HCV.It also reduced 25% of its employees during the first quarter in an effort to reduce costs. The reduction is expected to save $15 million through 2027, Atea said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2522641336","title":"Atea Pharmaceuticals Highlights Actions Underway to Enhance Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2522641336","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522641336?lang=en_us&edition=fundamental","pubTime":"2025-03-27 01:58","pubTimestamp":1743011880,"startTime":"0","endTime":"0","summary":"BOSTON, March  26, 2025  (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/26/3050010/0/en/Atea-Pharmaceuticals-Highlights-Actions-Underway-to-Enhance-Shareholder-Value.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2522335047","title":"Sector Update: Health Care Stocks Retreat Wednesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2522335047","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522335047?lang=en_us&edition=fundamental","pubTime":"2025-03-27 01:52","pubTimestamp":1743011572,"startTime":"0","endTime":"0","summary":"Health care stocks fell Wednesday afternoon, with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund  shedding 0.4%.The iShares Biotechnology ETF  declined 1.5%.In corporate news, Jaguar Health  shares fell more than 6% after the company signed securities purchase agreements to issue up to nearly $3.5 million in convertible promissory notes to Chief Executive Officer Lisa Conte, three board members, seven other senior executives and selected investors.Atea Pharmaceuticals  shareholder Radoff-JEC Group said in an open letter Wednesday that it plans to nominate three directors at the company's annual general meeting as it raised concerns about Atea's stock price performance, strategy and governance practices. Atea shares were down 0.6%.Wave Life Sciences  shares jumped past 6% after the company reported \"positive\" 48-week data from a phase 2 trial of its WVE-N531 drug candidate in boys with Duchenne muscular dystrophy.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JAGX","BK4007","XLV","BK4588","WVE","IBB","BK4585","BK4581","AVIR"],"gpt_icon":0},{"id":"2522160801","title":"Atea Shareholder Seeks Board Change, Plans to Nominate Directors at 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2522160801","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522160801?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:34","pubTimestamp":1742996087,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals  shareholder Radoff-JEC Group said in an open letter Wednesday that it plans to nominate three directors at the company's annual general meeting as it raised concerns about Atea's stock price performance, strategy and governance practices.Atea shares have traded below their net cash value since November 2021, according to the group, which said it owns about 5.4% of the company's outstanding stock.The group said in the letter that it has made suggestions to improve the governance and management of the business, and the board has \"ignored or rejected\" its ideas.There is an \"urgent need for boardroom change,\" the investor group said, adding that with a refreshed board focused on creating stockholder value Atea could \"immediately return up to $250 million in cash to stockholders.\"In a statement Friday, Atea said its nominating and corporate governance committee would evaluate the director candidates \"consistent with its established practices.\"Atea's 2025 annual meeting","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2522872897","title":"BRIEF-The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2522872897","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522872897?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:10","pubTimestamp":1742991044,"startTime":"0","endTime":"0","summary":"BRIEF-The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of DirectorsMarch 26 (Reuters) - Atea Pharmaceuticals Inc AVIR.O:THE RADOFF-JEC GR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA1VRMPV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2522871085","title":"the Radoff-Jec Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2522871085","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522871085?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:00","pubTimestamp":1742990403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA1VRMPV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVIR","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":78,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVIR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-06","symbol":"AVIR","fiscalQuarterEnding":"2024/12","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2024-11-07","symbol":"AVIR","fiscalQuarterEnding":"2024/09","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2024-08-07","symbol":"AVIR","fiscalQuarterEnding":"2024/06","expectedEps":-0.77,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2024-05-14","symbol":"AVIR","fiscalQuarterEnding":"2024/03","expectedEps":-0.61,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-0.75},{"market":"US","date":"2024-02-28","symbol":"AVIR","fiscalQuarterEnding":"2023/12","expectedEps":-0.44,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709096400000,"reportTimeType":"post","actualEps":-0.47}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVIR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVIR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0,"hold":0.3333,"sell":0.3333,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.3333,"analysts":3,"updateTime":1723521600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVIR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVIR","date":"2025-04-23","current":-1.457715,"percent":0.558659,"low":-466.703742,"twenty":-2.632085,"median":-1.599931,"eighty":27.04857,"high":114.976269,"avg":-9.819679,"sd":77.753398,"marketCap":245457263},"quantilePoints":[{"date":"2020-10-30","current":-171.312553,"twenty":-156.993218,"median":-135.514215,"eighty":-135.514215,"marketCap":2404200368},{"date":"2020-11-06","current":-192.938363,"twenty":-185.270517,"median":-169.618626,"eighty":-144.887281,"marketCap":2707696987},{"date":"2020-11-13","current":-182.492476,"twenty":-179.57892,"median":-166.738948,"eighty":-150.14975,"marketCap":2561099403},{"date":"2020-11-20","current":-187.291937,"twenty":-185.891624,"median":-173.26057,"eighty":-154.847576,"marketCap":2628455050},{"date":"2020-11-27","current":-194.462898,"twenty":-190.555572,"median":-181.814905,"eighty":-159.059809,"marketCap":2729092310},{"date":"2020-12-04","current":-165.157949,"twenty":-189.166551,"median":-180.855012,"eighty":-159.059809,"marketCap":2317826657},{"date":"2020-12-11","current":-67.833477,"twenty":-188.274415,"median":-172.131284,"eighty":-157.207782,"marketCap":2459506214},{"date":"2020-12-18","current":-77.722536,"twenty":-187.969508,"median":-166.738948,"eighty":-135.514215,"marketCap":2818063721},{"date":"2020-12-24","current":-78.565613,"twenty":-187.291937,"median":-160.979594,"eighty":-78.793471,"marketCap":2848631987},{"date":"2020-12-31","current":-95.199284,"twenty":-184.491311,"median":-158.946881,"eighty":-79.413246,"marketCap":3451735627},{"date":"2021-01-08","current":-109.508798,"twenty":-183.384611,"median":-157.817596,"eighty":-81.91969,"marketCap":3970569992},{"date":"2021-01-15","current":-121.767585,"twenty":-182.650576,"median":-148.839779,"eighty":-87.757425,"marketCap":4415049113},{"date":"2021-01-22","current":-123.658811,"twenty":-181.67939,"median":-135.514215,"eighty":-89.411678,"marketCap":4483621170},{"date":"2021-01-29","current":-166.336709,"twenty":-180.96794,"median":-133.570656,"eighty":-92.48321,"marketCap":6031036401},{"date":"2021-02-05","current":-196.09503,"twenty":-183.486247,"median":-135.514215,"eighty":-94.775467,"marketCap":7110013598},{"date":"2021-02-12","current":-186.912332,"twenty":-187.630723,"median":-154.457973,"eighty":-95.135484,"marketCap":6777067342},{"date":"2021-02-19","current":-190.558068,"twenty":-189.772842,"median":-158.862185,"eighty":-95.217512,"marketCap":6909254441},{"date":"2021-02-26","current":-171.71417,"twenty":-189.772842,"median":-159.511523,"eighty":-96.684921,"marketCap":6226012372},{"date":"2021-03-05","current":-136.669532,"twenty":-188.951987,"median":-160.201207,"eighty":-99.647082,"marketCap":4955363881},{"date":"2021-03-12","current":-154.624782,"twenty":-188.240537,"median":-158.890417,"eighty":-101.734266,"marketCap":5606385344},{"date":"2021-03-19","current":-177.934707,"twenty":-187.800115,"median":-159.27838,"eighty":-104.710098,"marketCap":6451556610},{"date":"2021-03-26","current":-137.079677,"twenty":-187.140095,"median":-158.946881,"eighty":-108.114304,"marketCap":4970234929},{"date":"2021-04-01","current":-436.925398,"twenty":-188.274415,"median":-159.045237,"eighty":-110.534161,"marketCap":4783022327},{"date":"2021-04-09","current":-427.100056,"twenty":-190.548954,"median":-160.935243,"eighty":-115.451347,"marketCap":4675464309},{"date":"2021-04-16","current":-339.654512,"twenty":-191.931363,"median":-165.157949,"eighty":-119.324942,"marketCap":3718197948},{"date":"2021-04-23","current":-275.185154,"twenty":-195.768604,"median":-167.331823,"eighty":-122.091144,"marketCap":3012451876},{"date":"2021-04-30","current":-186.757076,"twenty":-199.196041,"median":-171.312553,"eighty":-123.440067,"marketCap":2044429713},{"date":"2021-05-07","current":-161.135608,"twenty":-197.99537,"median":-168.007959,"eighty":-124.055285,"marketCap":1763951496},{"date":"2021-05-14","current":79.797223,"twenty":-196.113259,"median":-166.426176,"eighty":-123.440067,"marketCap":1895503226},{"date":"2021-05-21","current":78.125347,"twenty":-195.768604,"median":-164.402964,"eighty":-110.534161,"marketCap":1855789496},{"date":"2021-05-28","current":71.124369,"twenty":-194.157991,"median":-160.979594,"eighty":-99.246051,"marketCap":1689488253},{"date":"2021-06-04","current":74.990581,"twenty":-192.938363,"median":-159.511523,"eighty":-95.039783,"marketCap":1781326253},{"date":"2021-06-11","current":82.757835,"twenty":-192.37372,"median":-159.183468,"eighty":-82.507565,"marketCap":1965829623},{"date":"2021-06-18","current":81.469098,"twenty":-191.978471,"median":-158.890417,"eighty":-77.722536,"marketCap":1935216956},{"date":"2021-06-25","current":82.931989,"twenty":-191.742933,"median":-157.410556,"eighty":-69.975347,"marketCap":1969966469},{"date":"2021-07-02","current":81.08596,"twenty":-190.990999,"median":-154.624782,"eighty":67.989602,"marketCap":1926115893},{"date":"2021-07-09","current":80.075869,"twenty":-190.877549,"median":-153.804491,"eighty":71.451777,"marketCap":1902122181},{"date":"2021-07-16","current":79.762392,"twenty":-190.616292,"median":-149.016908,"eighty":72.482768,"marketCap":1894675857},{"date":"2021-07-23","current":87.459985,"twenty":-190.521611,"median":-146.01173,"eighty":76.523133,"marketCap":2077524488},{"date":"2021-07-30","current":87.21617,"twenty":-190.129695,"median":-138.834187,"eighty":78.278602,"marketCap":2071732902},{"date":"2021-08-06","current":108.532582,"twenty":-189.511691,"median":-136.601174,"eighty":79.811155,"marketCap":2578082956},{"date":"2021-08-13","current":64.910668,"twenty":-188.522858,"median":-135.134867,"eighty":80.20126,"marketCap":2290437846},{"date":"2021-08-20","current":69.578982,"twenty":-188.17278,"median":-133.639014,"eighty":79.908681,"marketCap":2455163951},{"date":"2021-08-27","current":73.543529,"twenty":-187.46133,"median":-129.708455,"eighty":79.811155,"marketCap":2595056974},{"date":"2021-09-03","current":67.819567,"twenty":-186.988253,"median":-125.64118,"eighty":79.769358,"marketCap":2393081248},{"date":"2021-09-10","current":67.092343,"twenty":-186.819178,"median":-123.385381,"eighty":79.6579,"marketCap":2367420398},{"date":"2021-09-17","current":61.532592,"twenty":-186.754529,"median":-116.674948,"eighty":79.170269,"marketCap":2171239057},{"date":"2021-09-24","current":75.396779,"twenty":-185.83684,"median":-107.184641,"eighty":78.431857,"marketCap":2660450755},{"date":"2021-10-01","current":98.550675,"twenty":-184.365164,"median":-99.847598,"eighty":79.353564,"marketCap":3477459123},{"date":"2021-10-08","current":93.976197,"twenty":-183.486247,"median":-95.199284,"eighty":79.950478,"marketCap":3316044096},{"date":"2021-10-15","current":92.146406,"twenty":-182.808676,"median":-92.009265,"eighty":81.232249,"marketCap":3251478085},{"date":"2021-10-22","current":29.86313,"twenty":-182.369073,"median":-82.507565,"eighty":81.232249,"marketCap":1053750408},{"date":"2021-10-29","current":27.306114,"twenty":-181.597122,"median":-78.679542,"eighty":81.099892,"marketCap":963523546},{"date":"2021-11-05","current":25.359029,"twenty":-180.96794,"median":-70.955139,"eighty":80.856077,"marketCap":894818688},{"date":"2021-11-12","current":38.198876,"twenty":-179.102829,"median":-70.055098,"eighty":80.32665,"marketCap":944047012},{"date":"2021-11-19","current":27.2705,"twenty":-177.005044,"median":-64.575101,"eighty":79.950478,"marketCap":673963140},{"date":"2021-11-26","current":27.371377,"twenty":-176.330583,"median":25.218276,"eighty":79.83902,"marketCap":676456222},{"date":"2021-12-03","current":27.102371,"twenty":-176.111839,"median":25.704021,"eighty":79.783291,"marketCap":669808003},{"date":"2021-12-10","current":26.799739,"twenty":-175.627494,"median":26.093598,"eighty":79.69273,"marketCap":662328758},{"date":"2021-12-17","current":28.750034,"twenty":-174.603768,"median":26.564359,"eighty":79.431789,"marketCap":710528341},{"date":"2021-12-23","current":30.633077,"twenty":-173.693594,"median":26.850178,"eighty":79.136017,"marketCap":757065870},{"date":"2021-12-31","current":30.061439,"twenty":-173.535454,"median":27.03512,"eighty":78.738368,"marketCap":742938406},{"date":"2022-01-07","current":25.690089,"twenty":-172.807662,"median":27.068745,"eighty":77.999956,"marketCap":634904857},{"date":"2022-01-14","current":24.546813,"twenty":-172.137986,"median":26.900617,"eighty":77.393902,"marketCap":606649929},{"date":"2022-01-21","current":21.654996,"twenty":-171.736956,"median":26.766114,"eighty":76.975933,"marketCap":535181581},{"date":"2022-01-28","current":22.865524,"twenty":-171.71417,"median":26.328978,"eighty":76.662456,"marketCap":565098564},{"date":"2022-02-04","current":23.000027,"twenty":-171.312553,"median":26.093598,"eighty":76.488302,"marketCap":568422673},{"date":"2022-02-11","current":22.66377,"twenty":-168.09122,"median":25.807779,"eighty":75.396779,"marketCap":560112400},{"date":"2022-02-18","current":19.906456,"twenty":-167.924698,"median":25.690089,"eighty":75.396779,"marketCap":491968161},{"date":"2022-02-25","current":21.419616,"twenty":-166.976098,"median":25.359029,"eighty":75.378012,"marketCap":529364390},{"date":"2022-03-04","current":3.948735,"twenty":-166.48873,"median":24.788709,"eighty":75.073047,"marketCap":478547148},{"date":"2022-03-11","current":3.976204,"twenty":-166.354602,"median":24.479561,"eighty":74.992061,"marketCap":481876171},{"date":"2022-03-18","current":4.862094,"twenty":-165.393701,"median":23.807046,"eighty":74.851258,"marketCap":589237184},{"date":"2022-03-25","current":4.745349,"twenty":-163.949973,"median":23.269033,"eighty":74.398458,"marketCap":575088833},{"date":"2022-04-01","current":4.875829,"twenty":-161.638082,"median":23.117718,"eighty":74.106492,"marketCap":590901696},{"date":"2022-04-08","current":4.573665,"twenty":-161.010797,"median":23.000027,"eighty":73.646748,"marketCap":554282436},{"date":"2022-04-14","current":4.525593,"twenty":-160.926372,"median":22.865524,"eighty":73.205722,"marketCap":548456644},{"date":"2022-04-22","current":4.044878,"twenty":-160.06327,"median":22.058506,"eighty":72.410188,"marketCap":490198730},{"date":"2022-04-29","current":4.032693,"twenty":-159.488323,"median":21.654996,"eighty":71.812079,"marketCap":488722059},{"date":"2022-05-06","current":3.792243,"twenty":-159.382162,"median":21.503681,"eighty":71.654826,"marketCap":459581902},{"date":"2022-05-13","current":12.540245,"twenty":-159.155821,"median":20.915229,"eighty":71.605033,"marketCap":606947838},{"date":"2022-05-20","current":12.884284,"twenty":-158.986223,"median":20.141837,"eighty":71.560583,"marketCap":623599356},{"date":"2022-05-27","current":14.071221,"twenty":-158.913003,"median":19.502947,"eighty":71.524315,"marketCap":681047094},{"date":"2022-06-03","current":13.417546,"twenty":-158.867831,"median":13.555162,"eighty":71.479642,"marketCap":649409209},{"date":"2022-06-10","current":13.27993,"twenty":-158.508321,"median":13.709979,"eighty":71.312455,"marketCap":642748602},{"date":"2022-06-17","current":11.181288,"twenty":-157.53242,"median":13.53796,"eighty":70.650671,"marketCap":541174341},{"date":"2022-06-24","current":12.265013,"twenty":-156.71581,"median":13.27993,"eighty":69.928889,"marketCap":593626623},{"date":"2022-07-01","current":12.557447,"twenty":-156.024233,"median":12.93589,"eighty":69.874563,"marketCap":607780414},{"date":"2022-07-08","current":13.606767,"twenty":-154.624782,"median":12.93589,"eighty":69.837029,"marketCap":658567544},{"date":"2022-07-15","current":13.933605,"twenty":-154.533639,"median":13.27993,"eighty":69.719735,"marketCap":674386487},{"date":"2022-07-22","current":13.761585,"twenty":-153.804491,"median":13.443349,"eighty":69.602441,"marketCap":666060728},{"date":"2022-07-29","current":14.105625,"twenty":-152.114706,"median":13.555162,"eighty":69.578982,"marketCap":682712246},{"date":"2022-08-05","current":15.120542,"twenty":-149.194038,"median":13.675575,"eighty":69.156722,"marketCap":731834224},{"date":"2022-08-12","current":45.098857,"twenty":-148.839779,"median":13.813191,"eighty":68.570251,"marketCap":700204851},{"date":"2022-08-19","current":44.187227,"twenty":-148.362663,"median":13.881999,"eighty":68.523333,"marketCap":686050888},{"date":"2022-08-26","current":41.988591,"twenty":-146.01173,"median":13.933605,"eighty":68.030697,"marketCap":651914861},{"date":"2022-09-02","current":39.95083,"twenty":-143.642002,"median":14.019615,"eighty":67.989602,"marketCap":620276592},{"date":"2022-09-09","current":42.256717,"twenty":-141.199359,"median":14.06262,"eighty":67.909876,"marketCap":656077791},{"date":"2022-09-16","current":35.98256,"twenty":-137.781481,"median":14.088423,"eighty":67.833642,"marketCap":558665226},{"date":"2022-09-23","current":31.10266,"twenty":-136.751561,"median":14.217438,"eighty":67.500527,"marketCap":482899897},{"date":"2022-09-30","current":30.512782,"twenty":-136.614846,"median":14.535674,"eighty":67.27063,"marketCap":473741451},{"date":"2022-10-07","current":28.957649,"twenty":-135.731607,"median":14.862512,"eighty":67.176794,"marketCap":449596456},{"date":"2022-10-14","current":28.15327,"twenty":-135.514215,"median":19.872831,"eighty":67.106418,"marketCap":437107665},{"date":"2022-10-21","current":28.528647,"twenty":-134.907259,"median":20.562159,"eighty":66.974213,"marketCap":442935767},{"date":"2022-10-28","current":31.638913,"twenty":-134.153974,"median":21.38599,"eighty":66.781304,"marketCap":491225757},{"date":"2022-11-04","current":32.389666,"twenty":-133.711929,"median":21.604558,"eighty":65.670736,"marketCap":502881962},{"date":"2022-11-11","current":12.077105,"twenty":-132.636436,"median":21.38599,"eighty":65.403305,"marketCap":430597093},{"date":"2022-11-18","current":10.909106,"twenty":-131.930075,"median":20.562159,"eighty":65.103031,"marketCap":388953274},{"date":"2022-11-25","current":10.955826,"twenty":-129.286916,"median":19.889643,"eighty":64.999812,"marketCap":390619026},{"date":"2022-12-02","current":11.212786,"twenty":-126.766801,"median":15.120542,"eighty":64.938819,"marketCap":399780667},{"date":"2022-12-09","current":10.255027,"twenty":-125.869038,"median":14.552876,"eighty":64.150601,"marketCap":365632735},{"date":"2022-12-16","current":10.768946,"twenty":-124.451759,"median":14.260443,"eighty":62.377111,"marketCap":383956015},{"date":"2022-12-23","current":10.722226,"twenty":-123.494753,"median":14.097024,"eighty":61.180709,"marketCap":382290263},{"date":"2022-12-30","current":11.236146,"twenty":-122.738263,"median":14.071221,"eighty":55.100568,"marketCap":400613543},{"date":"2023-01-06","current":10.979186,"twenty":-121.156924,"median":14.045418,"eighty":46.278613,"marketCap":391451903},{"date":"2023-01-13","current":11.516465,"twenty":-117.898548,"median":13.950807,"eighty":46.053387,"marketCap":410608060},{"date":"2023-01-20","current":11.446386,"twenty":-114.635614,"median":13.899201,"eighty":46.010486,"marketCap":408109431},{"date":"2023-01-27","current":10.745586,"twenty":-109.508798,"median":13.856196,"eighty":45.903236,"marketCap":383123139},{"date":"2023-02-03","current":10.535347,"twenty":-107.184641,"median":13.761585,"eighty":45.474234,"marketCap":375627251},{"date":"2023-02-10","current":9.834548,"twenty":-103.060402,"median":13.659535,"eighty":45.098857,"marketCap":350640960},{"date":"2023-02-17","current":9.927987,"twenty":-100.850175,"median":13.555162,"eighty":44.937981,"marketCap":353972465},{"date":"2023-02-24","current":8.573109,"twenty":-99.246051,"median":13.469152,"eighty":44.466079,"marketCap":305665635},{"date":"2023-03-03","current":-2.538161,"twenty":-95.964888,"median":13.331536,"eighty":44.219402,"marketCap":294195756},{"date":"2023-03-10","current":-2.401547,"twenty":-95.208398,"median":12.953092,"eighty":44.144327,"marketCap":278360857},{"date":"2023-03-17","current":-2.710728,"twenty":-95.071683,"median":12.884284,"eighty":43.9191,"marketCap":314197733},{"date":"2023-03-24","current":-2.157078,"twenty":-94.511151,"median":12.695062,"eighty":43.736775,"marketCap":250024722},{"date":"2023-03-31","current":-2.408737,"twenty":-90.587427,"median":12.600452,"eighty":43.532999,"marketCap":279194272},{"date":"2023-04-05","current":-2.415927,"twenty":-89.411678,"median":12.557447,"eighty":43.425749,"marketCap":280027688},{"date":"2023-04-14","current":-2.423117,"twenty":-86.44496,"median":12.505841,"eighty":43.221972,"marketCap":280861104},{"date":"2023-04-21","current":-2.344024,"twenty":-81.331815,"median":12.282215,"eighty":42.953846,"marketCap":271693531},{"date":"2023-04-28","current":-2.379976,"twenty":-79.258302,"median":12.230609,"eighty":42.578469,"marketCap":275860609},{"date":"2023-05-05","current":-2.396017,"twenty":-78.702328,"median":12.100465,"eighty":42.149467,"marketCap":277719925},{"date":"2023-05-12","current":-2.525658,"twenty":-78.228382,"median":11.92588,"eighty":41.83844,"marketCap":276051937},{"date":"2023-05-19","current":-2.739309,"twenty":-75.015577,"median":11.731751,"eighty":41.570314,"marketCap":299403763},{"date":"2023-05-26","current":-3.53287,"twenty":-70.863995,"median":11.512296,"eighty":41.205661,"marketCap":386139115},{"date":"2023-06-02","current":-3.113198,"twenty":-70.608794,"median":11.483414,"eighty":40.647959,"marketCap":340269458},{"date":"2023-06-09","current":-3.258176,"twenty":-70.102948,"median":11.446386,"eighty":40.186782,"marketCap":356115339},{"date":"2023-06-16","current":-3.166611,"twenty":-69.546973,"median":11.318087,"eighty":40.036631,"marketCap":346107414},{"date":"2023-06-23","current":-2.983482,"twenty":-67.833477,"median":11.259506,"eighty":39.95083,"marketCap":326091564},{"date":"2023-06-30","current":-2.861395,"twenty":-65.226776,"median":11.224466,"eighty":39.95083,"marketCap":312747663},{"date":"2023-07-07","current":-2.75457,"twenty":-28.146626,"median":11.197037,"eighty":39.182114,"marketCap":301071750},{"date":"2023-07-14","current":-2.861395,"twenty":-3.801459,"median":11.166066,"eighty":38.537448,"marketCap":312747663},{"date":"2023-07-21","current":-2.807983,"twenty":-3.706843,"median":11.072626,"eighty":38.299055,"marketCap":306909707},{"date":"2023-07-28","current":-2.540919,"twenty":-3.6107,"median":11.002546,"eighty":38.198876,"marketCap":277719925},{"date":"2023-08-04","current":-2.640114,"twenty":-3.548131,"median":10.967506,"eighty":37.383889,"marketCap":288561844},{"date":"2023-08-11","current":-2.663513,"twenty":-3.496244,"median":10.955826,"eighty":36.776214,"marketCap":282723888},{"date":"2023-08-18","current":-2.67137,"twenty":-3.448936,"median":10.920786,"eighty":36.282862,"marketCap":283557881},{"date":"2023-08-25","current":-2.639942,"twenty":-3.383314,"median":10.909106,"eighty":35.775559,"marketCap":280221906},{"date":"2023-09-01","current":-2.639942,"twenty":-3.29938,"median":10.885746,"eighty":34.557553,"marketCap":280221906},{"date":"2023-09-08","current":-2.577086,"twenty":-3.262754,"median":10.803986,"eighty":33.730299,"marketCap":273549956},{"date":"2023-09-15","current":-2.577086,"twenty":-3.258176,"median":10.768946,"eighty":33.569423,"marketCap":273549956},{"date":"2023-09-21","current":-2.498516,"twenty":-3.22155,"median":10.768946,"eighty":33.151146,"marketCap":265210018},{"date":"2023-10-06","current":-2.364948,"twenty":-3.197133,"median":10.768946,"eighty":32.872294,"marketCap":251032124},{"date":"2023-10-09","current":-2.33352,"twenty":-3.191029,"median":10.768946,"eighty":32.797219,"marketCap":247696149},{"date":"2023-10-17","current":-2.357091,"twenty":-3.184924,"median":10.757266,"eighty":32.722143,"marketCap":250198131},{"date":"2023-11-01","current":-2.553515,"twenty":-3.172715,"median":10.733906,"eighty":32.571992,"marketCap":271047975},{"date":"2023-11-10","current":-1.900308,"twenty":-3.162033,"median":10.710546,"eighty":32.464742,"marketCap":249364137},{"date":"2023-11-17","current":-1.850265,"twenty":-3.149824,"median":10.675507,"eighty":32.429404,"marketCap":242797342},{"date":"2023-11-24","current":-1.812115,"twenty":-3.14372,"median":10.628787,"eighty":32.407954,"marketCap":237791212},{"date":"2023-12-01","current":-1.901132,"twenty":-3.140668,"median":10.582067,"eighty":32.303866,"marketCap":249472183},{"date":"2023-12-08","current":-1.86934,"twenty":-3.129985,"median":10.535347,"eighty":32.153715,"marketCap":245300408},{"date":"2023-12-15","current":-1.894773,"twenty":-3.117777,"median":10.42211,"eighty":31.956565,"marketCap":248637828},{"date":"2023-12-22","current":-1.996506,"twenty":-3.10099,"median":10.266707,"eighty":31.681026,"marketCap":261987510},{"date":"2023-12-29","current":-1.971073,"twenty":-3.082677,"median":10.255027,"eighty":31.638913,"marketCap":258650090},{"date":"2024-01-05","current":-1.971073,"twenty":-3.064364,"median":10.231667,"eighty":31.638913,"marketCap":258650090},{"date":"2024-01-12","current":-2.276271,"twenty":-3.047577,"median":10.184947,"eighty":31.478037,"marketCap":298699136},{"date":"2024-01-19","current":-2.269913,"twenty":-3.035369,"median":10.004174,"eighty":31.263536,"marketCap":297864781},{"date":"2024-01-26","current":-2.397079,"twenty":-3.006373,"median":9.834548,"eighty":31.085409,"marketCap":314551884},{"date":"2024-02-02","current":-2.683202,"twenty":-2.946856,"median":9.577588,"eighty":31.055333,"marketCap":352097864},{"date":"2024-02-09","current":-2.708636,"twenty":-2.891917,"median":9.390708,"eighty":30.990254,"marketCap":355435285},{"date":"2024-02-16","current":-2.676844,"twenty":-2.888865,"median":8.806709,"eighty":30.896513,"marketCap":351263509},{"date":"2024-02-23","current":-2.562395,"twenty":-2.882761,"median":6.674963,"eighty":30.855984,"marketCap":336245117},{"date":"2024-03-01","current":-2.668137,"twenty":-2.882761,"median":4.999441,"eighty":30.721892,"marketCap":362749188},{"date":"2024-03-08","current":-2.525754,"twenty":-2.873604,"median":4.937635,"eighty":30.686879,"marketCap":343391343},{"date":"2024-03-15","current":-2.38337,"twenty":-2.861395,"median":4.862094,"eighty":30.626352,"marketCap":324033498},{"date":"2024-03-22","current":-2.538135,"twenty":-2.859869,"median":4.779686,"eighty":30.582117,"marketCap":345074634},{"date":"2024-03-28","current":-2.476229,"twenty":-2.853765,"median":4.714446,"eighty":30.512782,"marketCap":336658180},{"date":"2024-04-05","current":-2.38337,"twenty":-2.838504,"median":4.601134,"eighty":30.431323,"marketCap":324033498},{"date":"2024-04-12","current":-2.38337,"twenty":-2.823244,"median":4.553063,"eighty":30.405531,"marketCap":324033498},{"date":"2024-04-19","current":-2.290512,"twenty":-2.823244,"median":4.525593,"eighty":30.351906,"marketCap":311408816},{"date":"2024-04-26","current":-2.284321,"twenty":-2.815613,"median":4.46722,"eighty":30.08378,"marketCap":310567171},{"date":"2024-05-03","current":-2.372639,"twenty":-2.815613,"median":4.353909,"eighty":30.061439,"marketCap":322574473},{"date":"2024-05-10","current":-2.434588,"twenty":-2.807983,"median":4.312705,"eighty":30.030154,"marketCap":330996783},{"date":"2024-05-17","current":-1.904126,"twenty":-2.800352,"median":4.257766,"eighty":29.976529,"marketCap":311625470},{"date":"2024-05-24","current":-1.89898,"twenty":-2.792722,"median":4.22424,"eighty":29.910048,"marketCap":310783239},{"date":"2024-05-31","current":-1.85781,"twenty":-2.783638,"median":4.207069,"eighty":29.872514,"marketCap":304045391},{"date":"2024-06-07","current":-1.955589,"twenty":-2.778242,"median":4.154756,"eighty":29.844363,"marketCap":320047780},{"date":"2024-06-14","current":-1.904126,"twenty":-2.777461,"median":4.051745,"eighty":29.76091,"marketCap":311625470},{"date":"2024-06-21","current":-1.76003,"twenty":-2.777461,"median":4.044878,"eighty":29.688214,"marketCap":288043002},{"date":"2024-06-28","current":-1.739445,"twenty":-2.777461,"median":4.032693,"eighty":29.668025,"marketCap":284674078},{"date":"2024-07-05","current":-1.687982,"twenty":-2.777461,"median":3.976204,"eighty":29.559513,"marketCap":276251768},{"date":"2024-07-12","current":-1.734299,"twenty":-2.763867,"median":3.884237,"eighty":29.461726,"marketCap":283831847},{"date":"2024-07-15","current":-1.765176,"twenty":-2.759336,"median":3.860943,"eighty":29.451001,"marketCap":288885233},{"date":"2024-08-02","current":-1.868102,"twenty":-2.754805,"median":3.826593,"eighty":29.440276,"marketCap":305729853},{"date":"2024-08-09","current":-1.678875,"twenty":-2.75457,"median":3.661713,"eighty":29.440276,"marketCap":295477000},{"date":"2024-08-16","current":-1.793998,"twenty":-2.753144,"median":-1.61172,"eighty":29.220795,"marketCap":315738280},{"date":"2024-08-23","current":-1.813185,"twenty":-2.746785,"median":-1.641665,"eighty":29.220795,"marketCap":319115160},{"date":"2024-08-30","current":-1.813185,"twenty":-2.742082,"median":-1.683428,"eighty":29.17215,"marketCap":319115160},{"date":"2024-09-06","current":-1.736437,"twenty":-2.739864,"median":-1.687982,"eighty":29.086853,"marketCap":305607640},{"date":"2024-09-13","current":-1.760421,"twenty":-2.724943,"median":-1.693128,"eighty":29.001437,"marketCap":309828740},{"date":"2024-09-20","current":-1.832372,"twenty":-2.712853,"median":-1.726843,"eighty":28.985414,"marketCap":322492040},{"date":"2024-09-27","current":-1.650094,"twenty":-2.709176,"median":-1.703421,"eighty":28.963202,"marketCap":290411680},{"date":"2024-10-04","current":-1.59733,"twenty":-2.708666,"median":-1.687982,"eighty":28.871848,"marketCap":281125260},{"date":"2024-10-11","current":-1.602127,"twenty":-2.708636,"median":-1.687982,"eighty":28.797008,"marketCap":281969480},{"date":"2024-10-18","current":-1.789201,"twenty":-2.688289,"median":-1.687982,"eighty":28.756759,"marketCap":314894060},{"date":"2024-10-25","current":-1.621314,"twenty":-2.682118,"median":-1.687982,"eighty":28.750034,"marketCap":285346360},{"date":"2024-10-31","current":-1.573346,"twenty":-2.680275,"median":-1.687982,"eighty":28.629674,"marketCap":276904160},{"date":"2024-11-08","current":-1.668975,"twenty":-2.679227,"median":-1.678875,"eighty":28.536962,"marketCap":290411680},{"date":"2024-11-15","current":-1.606684,"twenty":-2.677797,"median":-1.672543,"eighty":28.464296,"marketCap":279572725},{"date":"2024-11-22","current":-1.57756,"twenty":-2.676844,"median":-1.669129,"eighty":28.421396,"marketCap":274504941},{"date":"2024-11-29","current":-1.660079,"twenty":-2.674654,"median":-1.659884,"eighty":28.357046,"marketCap":288863661},{"date":"2024-12-06","current":-1.422231,"twenty":-2.671016,"median":-1.660079,"eighty":28.23907,"marketCap":247476762},{"date":"2024-12-13","current":-1.431939,"twenty":-2.669546,"median":-1.652631,"eighty":28.185445,"marketCap":249166024},{"date":"2024-12-20","current":-1.519312,"twenty":-2.666287,"median":-1.650094,"eighty":28.152215,"marketCap":264369374},{"date":"2024-12-27","current":-1.596976,"twenty":-2.661942,"median":-1.641665,"eighty":28.145941,"marketCap":277883464},{"date":"2025-01-03","current":-1.660079,"twenty":-2.655656,"median":-1.640501,"eighty":28.127174,"marketCap":288863661},{"date":"2025-01-10","current":-1.621246,"twenty":-2.655656,"median":-1.640501,"eighty":28.070873,"marketCap":282106617},{"date":"2025-01-17","current":-1.616392,"twenty":-2.649327,"median":-1.635704,"eighty":27.992672,"marketCap":281261986},{"date":"2025-01-24","current":-1.50475,"twenty":-2.646707,"median":-1.633539,"eighty":27.93629,"marketCap":261835482},{"date":"2025-01-31","current":-1.451355,"twenty":-2.645438,"median":-1.630955,"eighty":27.830492,"marketCap":252544546},{"date":"2025-02-07","current":-1.50475,"twenty":-2.64209,"median":-1.626106,"eighty":27.755914,"marketCap":261835482},{"date":"2025-02-14","current":-1.509604,"twenty":-2.640114,"median":-1.621314,"eighty":27.677227,"marketCap":262680113},{"date":"2025-02-21","current":-1.524166,"twenty":-2.640045,"median":-1.616517,"eighty":27.578237,"marketCap":265214005},{"date":"2025-02-28","current":-1.485334,"twenty":-2.639942,"median":-1.616392,"eighty":27.458272,"marketCap":258456960},{"date":"2025-03-07","current":-1.523743,"twenty":-2.639942,"median":-1.616392,"eighty":27.391553,"marketCap":256575537},{"date":"2025-03-14","current":-1.554218,"twenty":-2.639942,"median":-1.609231,"eighty":27.345272,"marketCap":261707047},{"date":"2025-03-21","current":-1.599931,"twenty":-2.639443,"median":-1.606923,"eighty":27.291868,"marketCap":269404313},{"date":"2025-03-28","current":-1.533902,"twenty":-2.63621,"median":-1.610089,"eighty":27.2705,"marketCap":258286040},{"date":"2025-04-04","current":-1.472952,"twenty":-2.632425,"median":-1.606923,"eighty":27.2436,"marketCap":248023019},{"date":"2025-04-11","current":-1.36629,"twenty":-2.632236,"median":-1.606804,"eighty":27.162898,"marketCap":230062731},{"date":"2025-04-17","current":-1.523743,"twenty":-2.632085,"median":-1.601978,"eighty":27.088921,"marketCap":256575537},{"date":"2025-04-23","current":-1.457715,"twenty":-2.632085,"median":-1.599931,"eighty":27.04857,"marketCap":245457263}],"updateTime":1745508120331}}}